| HOME >> BIOLOGY >> TECHNOLOGY |
IRVINE, Calif., July 31 /PRNewswire-FirstCall/ -- Alsius Corporation (Nasdaq: ALUS), the worldwide leader in intravascular temperature management (IVTM(TM)) therapies for critically ill patients, today announced that it will hold a conference call to discuss the Company's second quarter results and provide a corporate update. Bill Worthen, president and CEO, will host the call beginning at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) on Thursday, August 7. A press release for the second quarter ended June 30, 2008 will be released following the market close on August 7.
To participate in the live call by telephone, please dial 800-949-2163 from the U.S. or +1-719-785-1756 for international callers. In addition, the live conference call is being webcast and can be accessed via the "Investor Relations" section of the Company's website at http://www.alsius.com. Beginning 90 minutes after the conference call concludes, a replay will be available on Alsius' website or by dialing 888-203-1112 from the U.S. or +1-719-457-0820 internationally, and entering passcode 4517103 when prompted. The telephone replay will be available through August 31, 2008.
About Alsius Corporation
Alsius, headquartered in Irvine, Calif., is a medical device company
that develops, manufactures and sells proprietary products to precisely
control patient temperature in hospital critical care settings. Controlling
body temperature, through cooling and warming, is becoming the standard of
care for patients in select critical conditions and those undergoing a
variety of surgical procedures. Alsius markets a comprehensive suite of
catheter-based intravascular temperature management products that address
'/>"/>
| SOURCE Alsius Corporation Copyright©2008 PR Newswire. All rights reserved |